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Abstract
Background: Malaria is a major public health problem in the world which is responsible for death of millions
particularly in sub-Saharan Africa. Today, the control of malaria has become gradually more complex due to the
spread of drug-resistant parasites. Medicinal plants are the unquestionable source of effective antimalarials. The
present study aimed to evaluate antiplasmodial activity and acute toxicity of the plant Strychnos mitis in
Plasmodium berghei infected mice.
Methods: Standard procedures were employed to investigate acute toxicity and 4-day suppressive effect of crude
aqueous and hydro-methanolic extracts of the leaves of Strychnos mitis against P. berghei in Swiss albino mice.
Water, n-hexane and chloroform fractions, obtained from crude hydro-methanolic extract, were also tested for their
suppressive effect against P. berghei.
Results: All crude extracts revealed no obvious acute toxicity in mice up to the highest dose administered
(2000 mg/kg). All crude and solvent fractions of the leaves of Strychnos mitis inhibited parasitaemia significantly (p
< 0.01). At the highest dose of 600 mg/kg, both aqueous and hydro-methanolic extracts demonstrated higher
performance with 95.5 and 93.97% parasitaemia suppression, respectively. All doses of crude extracts and fractions
of leaves of Strychnos mitis prolonged survival time of infected mice dose dependently. The highest two doses of
the crude aqueous and hydro-methanolic extracts, and chloroform and aqueous fractions prevented weight loss in
a dose dependent manner. Whereas, all doses of n-hexane fraction prevented loss of body weight but not in a
dose dependent manner. The crude aqueous extract at the doses of 400 mg/kg and 600 mg/kg and hydro-
methanolic extract at all dose levels significantly (p < 0.01) prevented packed cell volume reduction. Crude aqueous
extract at a dose of 600 mg/kg and hydro-methanolic extract at all dose levels significantly prevented temperature
reduction. Phytochemical screening of the crude aqueous and hydro-methanolic extracts revealed the presence of
alkaloids, anthraquinones, glycosides, terpenoids, saponins, tannins and phenols.
Conclusion: The results of this study provide support the traditional therapeutic use of Strychnos mitis for
treatment of malaria. However, further in-depth study is needed to evaluate the potential of the plant towards the
development of new antimalarial agent.
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Background
Malaria still remains to be a critical problem to global pub-
lic health. It continues to remain among the top three in-
fectious diseases (Malaria, tuberculosis and HIV) affecting
billions of people globally [1]. Malaria kills more than one
million individuals in the tropical and subtropical zones an-
nually [2]. Pregnant women and children under 5 years of
age are the most vulnerable to the disease [3]. In Ethiopia,
malaria affects four to five million people annually [4]
resulting in 70,000 deaths [5]. Since the year 2000, malaria
mortality rates have decreased worldwide and in Africa by
47 and 54%, respectively [6]. However, malaria control pro-
gram has been jeopardized by lack of access to effective
malaria control tools, emergence of resistance to antimalar-
ial drugs and insecticides [7]. This calls for more effort to
develop new antimalarial compounds with novel mecha-
nisms of action. In recent times, natural products of plant
sources have been the centre of focus as the main source of
new, safer and more effective bioactive compounds with
medicinal properties [8]. Medicinal plants have been the
focus for search of new antimalarial drugs in various parts
of the world. Artemisinin and quinine are drugs that have
been developed from the herbaceous plants Artemisia
annua L. and bark of Cinchona pubescens Vahl., respect-
ively, based on ethnobotanical leads [9]. Such discoveries
have inspired many researchers to look for new antimalarial
drugs from plants.
In Ethiopia, some traditionally used antimalarial plants
have been screened for their antiplasmodial activity. These
include Dodonaea viscosa subsp. angustifolia (L.f.) J.G.
West, Clerodendrum myricoides (Hochst.) Vatke, Aloe
debrana Christian, Adhathoda schimperiana Hochst. ex
Nees and Asparagus africanus Lam. Extracts of seeds of
Dodonaea viscosa subsp. angustifolia that were tested
against Plasmodium berghei in mice model significantly
reduced parasitaemia and prevented packed cell volume
reduction [10]. A study conducted by Deressa et al. [11]
revealed strong activities of crude extracts of Cleroden-
drum myricoides and Aloe debrana against P. berghei. A
study by Petros & Melaku [12] reported significant para-
sitaemia reduction by hydro-alcoholic extract of leaves of
A. schimperiana tested against chloroquine-sensitive P.
berghei. Dikasso et al. [13] also reported that hydro-
alcoholic extracts of Asparagus africanus demonstrated
appreciable in vivo antimalarial activity against P. berghei.
A report shows that the plant Strychnos mitis S.Moore
(Loganiaceae) is traditionally used in Asia to treat mal-
aria [14]. Some in vitro and in vivo studies indicate the
antmalarial activity of extracts from Strychnos species.
An in vitro study revealed a very promising activity by
methanolic extract of Strychnos variabilis De Wild. and
interesting activity by that of Strychnos mellodora
S.Moore and Strychnos gossweileri Excell, all close rela-
tives of Strychnos mitis [15]. An in vitro study conducted
on several alkaloids extracted from Strychnos species
showed high and selective activity of quasidimetric alka-
loids against Plasmodium falciparum [16]. Another
in vitro study demonstrated high activity of some com-
pounds extracted from Strychnos icaja Baill. [17]. Strych-
nos spinosa Lam. [18] and Strychnos usambarensis Gilg
ex Engl. [19] have been reported to have antiplasmodial
activity in vitro. Strychnos icaja was reported to show
potent antimalarial activity in vivo [20]. A study by
Sanmugapriya and Venkataraman [21] revealed the anti-
pyretic effect of the seeds of Strychnos potatorum, L.f.
on experimental rats. However, the there is no report
indicating evaluation of Strychnos mitis for its antiplas-
modial activity. Thus, the aim of this study was to evalu-
ate the in vivo antiplasmodial activity of the crude
extracts and solvent fractions of the leaves of Strychnos




For the in vivo test, plant samples of Strychnos mitis
were collected in February 2014 from around Yirgalem
town, South Region of Ethiopia, located at 318 km
south of Addis Ababa. Voucher specimen (SF-001) of
the plant was also collected, identified and deposited at
the National Herbarium of the Addis Ababa University
(AAU) for future referencing.
Preparation of crude extracts
Leaf samples of the plant were air-dried at room
temperature under shade in the preparation room of the
Aklilu Lemma Institute of Pathobiology (ALIPB), AAU.
The dried leaves were ground to powder using mortar and
pestle. Crude extracts were prepared by cold maceration
techniques as outlined by O’Neill et al. [22]. Leaf powders
(300 g each) were soaked in 2400 ml of 80% methanol and
2700 ml of distilled water in separate Erlenmeyer flasks.
The flasks containing the plant powders dissolved in
methanol and distilled water were placed on orbital shaker
(Thermoforma, USA) of 145 rotations per minute (rpm)
for 72 and 24 h, respectively. The mixtures were filtered
using gauze and filtrates were passed through Whatman
filter paper number 1 with pore size of 150 mm diameter
(Wagtech international Ltd, England). The residues were
re-macerated twice. The methanol in the filtrate of the
hydro-methanolic extract was removed under reduced
pressure by rotary evaporator (Buchi type TRE121,
Switzerland) at 45 rpm and 40 °C to obtain crude extract.
The extract was further concentrated to dryness with a ly-
ophilizer (Wagtech Jouan Nordic DK-3450 Allerod,
Denmark) at −50 °C and vacuum pressure (200 mBar).
The aqueous extract was frozen in deep freezer overnight
and then freeze dried with a lyophilizer (Wagtech Jouan
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Nordic DK-3450 Allerod, Denmark) at −50 °C and vacuum
pressure (200 mBar). All extracts were stored in screw cap
vials in a refrigerator (AKIRA, China) at −4 °C until use.
The water extract was dissolved in distilled water, and the
80% methanol extract in 2% Tween 80 before oral
administration.
Preparation of fraction of hydro-methanolic crude
extracts
The crude hydro-methanolic extract was subjected to
fractionation using n-hexane and chloroform. Forty
gram of the extract was suspended in a separatory fun-
nel in 240 ml of distilled water and partitioned with
3 × 240 ml n-hexane. The filtrate was concentrated in a
rotary evaporator (Buchi type TRE121, Switzerland) at
45 rpm and 40 °C to obtain the n-hexane fraction. The
aqueous residue was then partitioned with 3 × 240 ml
chloroform. The chloroform filtrate was concentrated
to obtain chloroform fraction using same method used
to get n-hexane fraction. The remaining aqueous resi-
due was frozen in deep freezer overnight and then
freeze dried with a lyophilizer (Wagtech Jouan Nordic
DK-3450 Allerod, Denmark) at −50 °C and vacuum
pressure (200 mBar) to obtain aqueous fraction. All
fractions were stored in screw cap vials in a refrigerator
(AKIRA, China) at −4 °C until use. The n-hexane and
chloroform fractions were separately dissolved in 3%
Tween 80 and aqueous fraction was dissolved in dis-
tilled water before oral administration.
Phytochemical screening
The 80% methanol and aqueous extracts of leaves of
Strychnos mitis were screened for the presence of sec-
ondary metabolites to relate the antimalarial activity
of the plant with the presence or absence of these con-
stituents. Thus, tests for alkaloids, saponins, cardiac
glycosides, flavonoids, terpenoids, steroids, phenols
and tannins were performed using standard proce-
dures [23, 24].
Experimental animals and parasite inoculation
Swiss albino mice, 6–8weeks of age and weighing 27–
32 g, obtained from the Ethiopian Public Health Insti-
tute (EPHI), were used for the tests. Female mice were
used for in vivo acute toxicity test and male mice were
used for in vivo antimalarial screening. The mice were
maintained in the animal house of ALIPB, AAU, under
standard condition at room temperature by exposing
them to 12 h light and 12 h dark cycle, with food and
water ad libitum. Mice were handled based on inter-
nationally accepted guideline [25].
Chloroquine sensitive P. berghei (ANKA strain) was
obtained from the Ethiopian public Health Institute
(EPHI). The parasites were maintained by serial passage
of blood from infected mice to non-infected ones on
weekly basis [26]. Donor mice infected with a rising
parasitaemia of 20–30% were used to infect mice in the
4-day suppressive test. The donor mice were sacrificed
and blood was pooled together in a petri-dish containing
2% trisodium citrate (BDH chemicals, England) as anti-
coagulant to avoid variability in parasitaemia. The blood
was then diluted with 0.9% normal saline so that each
0.2 ml of blood contained 1x107P. berghei infected
erythrocytes. Each mouse used in the experiment was
then inoculated intraperitoneally with 0.2 ml of the di-
luted blood.
In vivo acute toxicity test
Crude aqueous and 80% methanol extracts of S. mitis
were evaluated for their acute toxicity in non-infected
female Swiss albino mice of 6–8 weeks old and weigh-
ing 27–32 g according to OECD Guideline No. 425
[27]. The mice were fasted overnight and weighted be-
fore test. A single female mouse was given 2000 mg/kg
of the extract as a single dose by oral gavage. After ad-
ministration of the extract, food was withheld for fur-
ther 2 hours period. Death was not observed in the
first 24 h. Then, additional four mice were given the
same dose of the extract (2000 mg/kg). The mice were
then observed for toxic signs in the next 14 days.
In vivo antimalarial screening
In vivo antiplasmodial activity evaluation of the crude
extracts (hydro-methanolic and aqueous extract) and
three fractions (n-hexane, chloroform and aqueous
fraction) of the leaves of S. mitis was carried out
against P. berghei according to method described by
Peters et al. [28] by randomly assigning 30 male mice
into five groups (three treatment groups and two con-
trol groups). The three treatment groups received
200 mg/kg, 400 mg/kg and 600 mg/kg of the crude ex-
tracts and 100 mg/kg, 200 mg/kg and 400 mg/kg of
the fractions, respectively, once daily for 4 days. The
two controls (negative and positive) for crude extract
and fractions received the vehicle (distilled water) and
chloroquine phosphate (25 mg/kg) (standard drug), re-
spectively. The vehicle, the plant extracts and the
standard drug were administered orally (by oral gav-
age). The dose levels of the extracts and fractions were
determined based on result obtained from oral acute
toxicity test.
Treatment was started 3 hours after mice had been
inoculated intraperitoneally with 0.2 ml of infected
blood containing about 1×107 parasites at day 0 by
using a hypodermic needle [29] and then continued for
additional 3 days (from day 1 to day 3). On the 5th day
(day 4), thin films were made from the tail blood of
each mouse and smeared onto a microscope slide to
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make a film [30]. The blood films were fixed with
methanol, stained with 10% Giemsa at pH 7.2 for
15 min and parasitaemia was examined microscopically
to determine parasitaemia level and percentage parasite
suppression. Moreover, each mouse was observed daily
for determination of survival time.
Determination of body weight and temperature
The body weight of each mouse in all the groups was
taken before infection (day 0) and on day 4 using a sensi-
tive weighing balance (METTLER TOLEDO, Switzerland).
The rectal temperature of the mice was measured with a
digital thermometer before infection and then daily up to
day 4 to see the effect of the extracts and fractions on
body temperature.
Determination of packed cell volume
Packed cell volume (PCV) was measured to predict the
effectiveness of the test extracts and fractions in prevent-
ing hemolysis resulting from increasing parasitaemia as-
sociated with malaria. Blood was collected from tail of
each mouse in heparinized microhaematocrit capillary
tubes. The capillary tubes were filled with blood up to
¾th of their volume and sealed.
The tubes were sealed by crystal seal and placed in a
microhematocrit centrifuge (Hettichhaematokrit, Germany)
with sealed ends outwards and centrifugedfor 5 min at
11,000 rpm. PCV is a measure of the proportion of RBCs
to plasma and measured before inoculating the parasite
(day0) and after treatment (day4) [13] using the following
relationship [10].
PCV ¼Volume of erythrocyte in a given volume of blood
Total blood volume examined
Determination of parasitaemia
On day 4 of the experiment, thin smears were prepared
from tail blood on microscopic slides, dried and fixed
with methanol. The blood films were stained with
Giemsa and examined under the microscope. Five differ-
ent fields on each slide were examined and the average
was taken and percentage parasitaemia was determined
using the formula described by Fidock et al. [26].
Table 1 Result of phytochemical screening of hydro-methanolic
and aqueous extracts of leaves of Strychnos mitis
Phytochemical Test results









Note: + indicates the presence and − the absence of particular metabolites
Table 2 Effect of crude extract of the leaves of S. mitis on


















600 2.01 ± 0.55 95.50 a3,b3,c2 17.50 ± 1.04
a3,b2,c3,e3
Vehicle 1 ml 44.85 ± 5.81 0.00 7.33 ± 0.81
CQ 25 0.00 100 27.50 ± 0.83
HE 200 28.45 ± 5.27 36.56a3,c3,d3,e3 10.83 ±
1.72a2,d3,e3
400 8.30 ± 5.03 81.49a3,b3,e2 13.00 ±
2.00a3,e3,d2
600 2.70 ± 1.10 93.97a3,b3 16.50 ±
1.04a3,b3,c2,e3
Vehicle 1 ml 44.85 ± 5.81 0.00 7.33 ± 0.81
CQ 25 0.00 100 27.50 ± 0.83
Data are expressed as mean ± SEM; n = 6; a = compared to distilled water
(vehicle); b = compared to200 mg/kg; c = compared to 400 mg/kg; d =
compared to 600 mg/kg; e = compared to chloroquine (25 mg/kg)
AE aqueous extract, CQ chloroquine, HE hydro-methanolic extract
1 = p < 0.05, 2 = p < 0.01, 3 = p < 0.001
Table 3 Effect of crude extracts of S. mitis leaves on body





Body weight % change
D0 (g) D4 (g)
AE 200 30.33 ± 1.93 28.28 ± 3.82 −8.29 ± 9.97 c1,e2,d2
400 29.83 ± 1.40 30.35 ± 1.35 1.65 ± 3.53 a1,b1
600 29.40 ± 1.69 30.76 ± 1.73 4.41 ± 2.72 a2,b2
Vehicle 1 ml 29.26 ± 1.26 27.30 ± 1.10 −7.18 ± 1.52
CQ 25 29.11 ± 1.54 30.12 ± 2.03 3.21 ± 3.50
HE 200 31.33 ± 0.54 29.88 ± 2.58 −5.43 ± 8.30
400 29.63 ± 1.45 30.16 ± 1.32 1.73 ± 3.442 a1
600 30.41 ± 1.92 32.45 ± 2.23 6.22 ± 1.02 a3,b2
Vehicle 1 ml 29.26 ± 1.26 27.30 ± 1.10 −7.18 ± 1.52
CQ 25 29.11 ± 1.54 30.12 ± 2.03 3.21 ± 3.50
Data are expressed as mean ± SEM; n = 6; a = compared to distilled water
(vehicle); b = compared to200 mg/kg; c = compared to 400 mg/kg; d =
compared to600 mg/kg; e = compared to CQ 25 mg/kg
D0 pre-treatment value on day 0, D4 post-treatment value on day four, AE
aqueous extract, CQ chloroquine, HE hydro-methanolic extract
1 = p < 0.05, 2 = p < 0.01, 3 = p < 0.001
Fentahun et al. BMC Complementary and Alternative Medicine  (2017) 17:13 Page 4 of 12
% Parasitaemia ¼ Number of infected RBCs
Total number of RBCs examined
 100
The percentage suppression of parasitaemia was calcu-
lated for each test concentration by comparing the para-
sitaemia in infected controls with those received
different concentrations of the test extract.
% Suppression ¼
Parasitaemia in negative control ‐ parasitaemia in test group
Parasitaemia in negative control
 100
Determination of mean survival time
Mortality was monitored daily and the number of
days from the time of inoculation of the parasite up
to death was recorded for each mouse in the treat-
ment and control groups throughout the follow up
period. The mean survival time (MST) for each group
was calculated as follows:
MTS ¼ Sum of survival time of all mice in group daysð Þ
Total number of mice in that group
Data analysis
Results of the study were expressed as a mean plus or minus
standard error of mean (M± SEM). Data were analyzed
using Windows SPSS Version 16.0. One-way analysis of
variance (ANOVA) followed by Tukey’s (post-hoc test) was
used to determine statistical significance for comparison of
parasitaemia, % suppression, body weight, PCV, rectal
temperature and survival time among groups. The analysis
was performed with 95% confidence interval and P-values
less than 0.05 was considered to be statistically significant.
Results
Acute toxicity
The in vivo acute toxicity test indicated that both hydro-
methanolic and aqueous extracts of leaves of S. mitis did
not cause mortality and body weight reduction up to
2000 mg/kg oral doses within the first 24 h as well as for
Fig. 1 The effect of aqueous extract of leaves of S. mitis on packed cell volume of P. berghei infected mice on 4 day suppression test; data are
mean ± SEM; n =6; CQ = chloroquine, AE = aqueous extract of S. mitis; numbers refer to doses in mg/kg/day
Fig. 2 The effect of hydro-methanolic extract of leaves of S. mitis on packed cell volume of P. berghei infected mice on 4 day suppression test;
data are mean ± SEM; n = 6; CQ = chloroquine, HE = hydro-methanolic extract of S. mitis; numbers refer to doses in mg/kg/day
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the subsequent 14 days. Gross physical and behavioral
observation also revealed no visible signs of toxicity such
as lacrimation, hair erection, and reduction in their
motor and feeding activities.
Extract yield
The leaves of S. mitis yielded a total of 56.8 g (18.8%) of
dried hydro-methanolic crude extract and 43.3 g (14.4%)
of dried aqueous crude extract.
Phytochemical screening
Phytochemical screening of leaves of Strychnos mitis for
the presence or absence of different secondary metabo-
lites including alkaloids, tannins, saponins, flavonoids,
terpenoids, steroids, phenols and glycosides gave the fol-
lowing results as shown in Table 1.
In vivo antiplasmodial activity of crude extracts on
parasitaemia and survival time
The 4-day suppressive test results indicated that both
hydro-methanolic and aqueous extract of the leaves of S.
mitis had prominent antiplasmodial activity against chloro-
quine sensitive P. berghei infected Swiss albino mice
(Table 2). The level of suppression of hydro-methanolic
extract at concentrations of 200 mg/kg/day, 400 mg/kg/day
and 600 mg/kg/day following the 4-day test was 36.56,
81.49 and 93.97%, respectively, and that of aqueous extract
at concentrations of 200 mg/kg/day, 400 mg/kg/day and
600 mg/kg/day was 29.43, 74.86 and 95.5%, respectively.
Both hydro-methanolic and aqueous extracts of S.
mitis showed statistically significant (p < 0.001) differ-
ence in reducing parasite load at all dose levels as com-
pared to the negative control after the 4-day
suppressive test. The respective two doses of both
extracts (400 mg/kg and 600 mg/kg) demonstrated a
statistically significant (P < 0.001) parasitaemia reduc-
tion as compared to the same extracts at a dose of
200 mg/kg. At higher dose (600 mg/kg), both aqueous
and hydro-methanolic extracts showed higher percent-
age suppression, that is, 95.5 and 93.97% respectively,
which is comparable to that of CQ (25 mg/kg) (100%).
There was significant difference in mean survival
time (p < 0.01) between P. berghei infected mice
treated with respective 200 mg/kg, 400 mg/kg and
600 mg/kg of hydro-methanolic and aqueous extracts
of the leaves of S. mitis and infected mice in the
negative control group following the 4-day suppres-
sive test (Table 2).
Fig. 3 The effect of hydro-methanolic extract of S. mitis leaves on rectal temperature of P. berghei infected mice on 4-day suppression test; data
are mean ± SEM; n = 6; CQ = chloroquine, AE = aqueous extract of S. mitis; numbers refer to doses in mg/kg/day
Fig. 4 The effect of aqueous extract of S. mitis leaves on rectal temperature of P. berghei infected mice on 4-day suppression test; data are mean
± SEM; n = 6; CQ = chloroquine, AE = aqueous extract of S. mitis; numbers refer to doses in mg/kg/day
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Effect of crude extracts on body weight
Two dose levels (400 mg/kg and 600 mg/kg) of the
hydro-methanolic and aqueous extracts significantly
protected parasite-induced weight reduction in infected
mice as compared to those in the negative control
groups (Table 3).
Effect of crude extracts of the leaves of S. mitis on packed
cell volume and rectal temperature
The aqueous extract of the leaves of S. mitis signifi-
cantly prevented reduction in PCV significantly at the
higher two doses (400 mg/kg 600 mg/kg) as compared
to the negative control with respective p values of <0.05
and <0.01 (Fig. 1). On the other hand, all the three
doses of hydro-methanolic extract significantly (p <
0.01) prevented reduction in PCV as compared to the
negative control (Fig. 2).
All the three doses of the hydro-methanolic extract of
the plant significantly prevented reduction in rectal
temperature as compared to the negative control: 600 mg/
kg with p value <0.001 and 200 mg/kg and 400 mg/kg with
p values < 0.01. At the dose level of 600 mg/kg, the effect
of the extract on rectal temperature is comparable to CQ
(25 mg/kg) (Fig. 3). Whereas, the aqueous extract of the
plant significantly (p < 0.05) prevented reduction in rectal
temperature only at the dose of 600 mg/kg as compared to
the negative control (Fig. 4).
Effect of fractions of leaves of S. mitis on parasitaemia,
percent suppression and survival time
At all dose levels evaluated, all the fractions showed sta-
tistically significant (p < 0.001) difference in reducing
parasite load in mice as compared to the negative con-
trol after 4-day suppressive test. The percent suppres-
sions of the solvent fractions n-hexane, chloroform and
aqueous were 42.85%), 39.72 and 34.47%, respectively.
Survival dates were significantly prolonged by all dose
levels as compared to negative control (Table 4).
Effect of fractions of leaves of S. mitis on body weight
All tested doses of the n-hexane fraction and the highest
two doses (200 mg/kg and 400 mg/kg) of chloroform
and aqueous fractions of S. mitis significantly protected
the mice from body weight loss as compared to negative
control after 4-day suppressive test (Table 5).
Effect of fractions of leaves of S. mitis on packed cell
volume and rectal temperature
None of the doses of the fractions of S. mitis signifi-
cantly improved body temperature of P. berghei infected
mice as compared to the negative control as indicated in
Figs. 5, 6 and 7.
Table 4 Effect of fractions of leaves of S. mitis on percent












NF 100 28.68 ± 6.31 42.11 a3,e3 11.33 ± 1.21a3,e3
200 28.31 ± 0.89 42.85 a3,e3 11.50 ± 1.76
a3.e3
400 32.81 ± 4.38 33.77 a3,e3 11.00 ± 1.54
a3,e3
CF 100 36.25 ± 2.14 26.84 a3,d3.e3 10.50 ± 0.54
a3,e3
200 33.83 ± 3.19 31.71a3,d1,e3 10.83 ± 0.75
a3,e3




AF 100 37.26 ± 1.84 24.78 a3,d3,e3 10.16 ± 1.47
a2,e3
200 36.10 ± 2.52 27.14a3,d2,e3 10.66 ± 1.36
a3,e3




Vehicle 1 ml 49.55 ± 2.53 0.00 7.33 ± 1.03
CQ 25 0.00 100 27.83 ± 0.75
Data are expressed as mean ± SEM; n = 6; a = compared to distilled water
(vehicle); b = compared to100 mg/kg; c = compared to 200; d = compared
to400 mg/kg; e = compared to chloroquine 25 mg/kg
CQ chloroquine, NF n-hexane fraction of crude hydro-methanolic extract, CF
chloroform fraction of crude hydro-methanolic extract, AF aqueous fraction of
Crude hydro-methanolic extract
1 = p < 0.05, 2 = p < 0.01, 3 = p = <0.001






Body weight % Change
D0 (g) D4 (g)
NF 100 29.45 ± 1.46 30.48 ± 2.12 3.26 ± 2.68 a2
200 29.40 ± 1.65 30.36 ± 2.47 2.94 ± 4.73 a2
400 30.25 ± 1.63 30.86 ± 2.34 1.73 ± 5.74 a1
CF 100 29.68 ± 1.55 29.28 ± 1.56 −1.40 ± 2.86
200 29.75 ± 1.42 30.40 ± 2.37 1.89 ± 4.47 a2
400 30.46 ± 1.70 31.11 ± 2.35 1.89 ± 4.02 a2
AF 100 29.43 ± 2.06 28.93 ± 2.02 −1.79 ± 4.07
200 29.41 ± 1.79 29.75 ± 2.26 1.00 ± 2.75 a1
400 30.76 ± 0.91 31.35 ± 1.28 1.70 ± 5.20 a2
Vehicle 1 ml 30.51 ± 1.78 28.20 ± 1.59 −8.39 ± 7.04
CQ 25 29.23 ± 2.00 30.74 ± 2.53 4.79 ± 2.10 a3
Data are expressed as mean ± SEM; n = 6; a = compared to distilled water
(vehicle), b = compared to100 mg/kg, c = compared to 200, d = compared
to400 mg/kg, e = compared to chloroquine 25 mg/kg
D0 pre-treatment value on day 0, D4 post-treatment value on day four, CQ
chloroquine, NF n-hexane fraction of crude hydro-methanolic extract, CF
chloroform fraction of crude hydro-alcoholic extract, AF aqueous fraction of
crude hydro-methanolic extract
1 = p < 0.05, 2 = p < 0.01, 3 = p < 0.001
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All dose levels of chloroform fraction of S. mitis
significantly (p < 0.01) prevented reduction in PCV as
compared to the negative control (Fig. 8). Similarly,
all dose levels of aqueous fraction demonstrated sig-
nificantly prevented PCV reduction (400 mg/kg, p <
0.01; 20 mg/kg, p < 0.01; 100 mg/kg, p < 0.05) as com-
pared to the negative control (Fig. 9). The n-hexane
fraction also significantly prevented PCV reduction
(400 mg/kg, p < 0.05; 100 mg/kg, p < 0.01; 200 mg/kg,
p < 0.01) as compared to the negative control
(Fig. 10).
Discussion
The observation that no death caused by an oral dose
of 2000 mg/kg body weight of the hydro-methanolic
and aqueous extracts of the leaves of S. mitis could
imply the safety of the plant to be used in the treat-
ment of malaria as also suggested in Akele [31] and
Murithi et al. [32]. The acute toxicity result of the
present study suggested that the oral medial lethal
dose (LD50) of the extract could be greater than
2000 mg/kg body weight as per OECD guideline No
425 [27]. The experimental determination of lack of
acute toxicity at the extract dose of up to 2000 mg/
kg body weight of mice may justify the use of this
plant for malaria treatment.
In vivo antiplasmodial activity can be classified as
moderate, good and very good if an extract displayed
a respective percent parasite suppression equal to or
greater than 50% at doses of 500, 250 and 100 mg/kg
body weight per day [33, 34]. Based on this classifica-
tion, the crude extracts of S. mitis are considered to
have exhibited good antiplasmodial activity, with dose
dependent inhibition against P. berghei infection in
mice.
Analysis of test results indicated significant parasit-
aemia suppression by all the doses of hydro-
methanolic and aqueous extracts of S. mitis as com-
pared to the negative control after the 4-day suppres-
sion test. The parasite suppression exhibited by these
extracts is comparable to results of former studies
conducted on methanol extract of the leaves of Aloe
debrana [11], crude extract of Croton macrostachyus
Del. [35] and hexane extract of Ficus thonningii [36].
Different studies [15, 17–20] revealed the antiplasmo-
dial activity of Strychnos gossweileri, Strychnos icaja,
Strychnos mellodora, Strychnos spinosa, Strychnos
usambarensis and Strychnos variabilis, all close rela-
tives of S. mitis.
The n-hexane and chloroform fractions of S. mitis
were found to demonstrate higher percentage of parasit-
aemia as compared to the aqueous fraction of the plant
Fig. 5 The effect of n-hexane fraction of leaves of S. mitis on rectal temperature of P. berghei infected mice on 4-day suppression test. Data are
mean ± SEM; n = 6; CQ = chloroquine, NF = hexane fraction; numbers refer to doses in mg/kg/day
Fig. 6 The effect of chloroform fraction of leaves of S. mitis on rectal temperature of P. berghei infected mice on 4-day suppression test. Data are
mean ± SEM; n = 6; CQ = chloroquine, CF = chloroform fraction; numbers refer to doses in mg/kg/day
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possibly suggesting the better availability of active ingre-
dients in the former two fractions.
All the crude extracts and fractions of the plant
prolonged the mean survival time of the experimental
mice indicating that the plant suppressed P. berghei
and reduced the overall pathologic effect of the para-
site on the mice. However, neither the extracts nor
the standard drug cured the infection. This could be
due to recrudescence of P. berghei parasites after ap-
parent cure. Similar result on mean survival time of
mice was reported by Bantie et al. [35] and Mengiste
et al. [10] in studies conducted on Croton macrosta-
chyus and Dodonaea viscosa subsp. angustifolia, re-
spectively. The longest survival time of mice as a
result of the administration of the highest dose
(600 mg/kg) of hydro-methanolic and aqueous ex-
tracts could be linked to the presence of active sec-
ondary metabolites in sufficient concentration in that
dose. The phytochemical screening of hydro-
methanolic and aqueous extract of S. mitis indicated
the presence of alkaloids, anthraquinones, terpenoids,
glycosides, saponins, tannins and phenolic com-
pounds. As explained by Dharani et al. [37], common
antimalarial plants used to treat malaria in traditional
medicine contain secondary metabolites, such as alka-
loids, terpenoids, coumarins, flavonoids, chalcones,
quinines and xanthones. Alkaloids, terpenoids and
tannins detected in S. mitis have been implicated for
their antiplasmodial activity in previous study [38,
39]. Quinine, one of the most important and oldest
antimalarial drugs, belongs to the class of alkaloids
[40]. Phenolic compounds present in S. mitis could
also possibly be responsible for the antiplasmodial ac-
tivity as these metabolites have been proved to pos-
sess potential antimalarial effect in other studies [41,
42]. Phenolic compounds detected in the leaf extract
of S. mitis were indicated to have antioxidant proper-
ties (free radical inhibitors or scavengers) in a study
conducted by Adamu et al. [43] and that may con-
tribute to the antiplasmodial activity of the plant. An-
tioxidative activity inhibits heme polymerization as
heme needs to be oxidized before polymerization;
unpolymerised heme is very toxic to the parasite [44].
Anemia, body weight loss and body temperature reduc-
tion are the general features of malaria-infected mice [45].
Thus antimalarial agents are expected to prevent body
weight loss in infected mice due to rise in parasitaemia.
The crude extracts (aqueous and hydro-methanolic) and
fractions (chloroform and aqueous) of leaves of S. mitis
significantly prevented weight loss at their higher two
doses in a dose dependent manner. Whereas, n-hexane
fraction of the plant significantly prevented weight loss at
Fig. 7 The effect of aqueous fraction of leaves of S. mitis on rectal temperature of P. berghei infected mice on 4-day suppression test. Data are
mean ± SEM; n = 6; CQ = chloroquine, AF = aqueous fraction; numbers refer to doses in mg/kg/day
Fig. 8 The effect of chloroform fraction of leaves of S. mitis on packed cell volume of P. berghei infected mice on 4-day suppression test. Data are
mean ± SEM; n = 6; CQ = chloroquine, CF = chloroform fraction; numbers refer to doses in mg/kg/day
Fentahun et al. BMC Complementary and Alternative Medicine  (2017) 17:13 Page 9 of 12
all dose levels in a dose independent manner suggesting
the possibility of localization of appetite-suppressing com-
ponents, and nutrients and other immunomodulatory
substances even at the lower dose of this fraction. Com-
parable effects in preventing weight loss were also re-
ported in studies conducted on hydro-alcoholic extract of
Asparagus africanus obtained [13, 35].
A decrease in the metabolic rate of infected mice oc-
curs before death and is accompanied by a correspond-
ing decrease in internal body temperature [10]. All the
doses of hydro-methanolic extract and the highest dose
of aqueous extract demonstrated protective effect
against temperature reduction, likely suggesting the
presence of constituents in the extracts responsible for
such effect. A study by Sanmugapriya and Venkatara-
man [21] revealed the antipyretic effect of the seeds of
Strychnos potatorum, a close relative of S. mitis. The ef-
fects on rectal temperature by S. mitis is comparable to
that reported in previous study conducted on crude ex-
tract and chloroform fraction of Croton macrostachyus
[35]. Unlike the crude extracts of S. mitis, all fractions
of the plant failed to significantly prevent parasite in-
duced rectal temperature reduction as compared to the
negative control. This could be attributed to the effect
by the fractions themselves as they may have
hypothermic effect on the treated mice.
Both the crude extracts and fractions of the leaves of
S. mitis significantly prevented PCV reduction in a dose
dependent manner as compared to the negative control.
Comparable effects on PCV were reported by previous
studies conducted on Dodonaea viscosa subsp. angustifo-
lia [10] and Croton macrostachyus [35].
Conclusion
The present study indicated promising in vivo antiplas-
modial effect of the crude extracts and solvent fractions
of S. mitis. The extracts were also found to be safe at the
maximum dose of 2000 mg/kg. The antimalarial effect
of the solvent fractions of the hydro-methanolic extract
was revealed to be less as compared to that by the crude
hydro-methanolic extract. The n-hexane fraction had
protected body weight loss at all dose levels and dis-
played greater parasite suppression as compared to the
other fractions. Therefore, the extracts and fractions of
hydro-methanolic extract could potentially be used as a
new source for the development of new plant-based
antimalarial agent. Moreover, the data could be used as
additional evidence to uphold claims by the Ethiopian
Fig. 9 The effect of aqueous fraction of leaves of S. mitis on packed cell volume of P. berghei infected mice on 4-day suppression test. Data are
mean ± SEM; n = 6; CQ = chloroquine, AF = aqueous fraction; numbers refer to doses in mg/kg/day
Fig. 10 The effect of n-hexane fraction of leaves of S. mitis on packed cell volume of P. berghei infected mice on 4 day suppression test. Data are
mean ± SEM; n = 6; CQ = chloroquine, NF = hexane fraction; numbers refer to doses in mg/kg/day
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traditional medicine practitioners on the effect of trad-
itionally used plants to manage malaria.
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